Building on the work of University of Sydney researchers, Kira Biotech has raised $13.6m from investors including IP Group to progress antibodies for autoimmune diseases.

Sino Biopharmaceutical has co-led the series D round together with Loyal Valley Capital, while K. Wah Group also contributed.

Merck Global Health Innovation Fund and Bristol-Myers Squibb have provided the final tranche for PathAI’s $75m series B round, adding to an earlier commitment from LabCorp.

Chinese Academy of Sciences' Cash Capital put up a share of the funds for oncological drug developer OnQuality Pharmaceuticals' first funding round.

Sensely has collected funding from a consortium led by insurance firm Aflac to haul its lifetime total to $26.5m.

Stanford-StartX Fund portfolio company Sensely collected funding from a consortium led by insurance firm Aflac to haul its lifetime total to $26.5m.

Genomics bioinformatics platform developer PierianDx has raised capital from investors including Inova Health Systems and RTI International to advance its business strategy.

Genomics bioinformatics platform developer PierianDx, a Washington University in St Louis spinout, has raised fresh capital to advance its business strategy.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.